MedImmune announced today it will present four abstracts at the 47th Annual Meeting of Infectious Disease Society of America (IDSA) being held here October 29 through November 1, 2009. These abstracts advance the body of data surrounding respiratory syncytial virus (RSV) and influenza prevention, highlighting MedImmune’s leadership in pediatric health.
As cough and cold season approaches, new educational materials and PSAs provide important safety information for parents and caregivers
MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2009 National Conference & Exhibition that add to the company’s growing body of research on the burden of respiratory syncytial virus (RSV) on children, as well as pediatric infectious disease prevention.
Company initiates clinical trial for patients with newly-diagnosed glioblastoma multiforme (GBM).
The results of a new clinical study demonstrate that the plaque and gingivitis germ-killing action of LISTERINE® Antiseptic significantly reduces the amount of germs that travel from the mouth to the bloodstream in people with mild to moderate gingivitis. These findings are significant, as emerging science suggests that gingivitis, if left untreated and allowed to progress to advanced gum disease, could contribute to broader health problems such as diabetes, cardiovascular disease, and pneumonia.
Two leading experts in the diagnosis and treatment of fibromyalgia are available for interviews about the signs, symptoms, current treatment landscape and other important aspects of the condition.
Study of nearly 1 million pain medication monitoring tests highlights an important opportunity to improve patient care and doctor-patient communication.
Until now, all regular body washes caused dry skin damage. Now, Dove has discovered how to restore skin's natural moisture while cleansing with body wash. Current body washes actually damage proteins and lipids in the skin's outer layer, often leading to the loss of critical moisture. Recognizing skin lipids require different care than skin proteins, Dove developed its latest liquid cleansing technology called NutriumMoisture. Research published in the June 2009 issue of Cosmetic Dermatology confirms NutriumMoisture is clinically proven to preserve both skin's natural proteins and lipids while significantly reducing dryness and improving moisturization.
MedImmune increases eligibility to its Patient Assistance Program to 400 percent of federal poverty level; as many as 75 percent of U.S. households may now qualify.
MedImmune today announced results from a recent study it sponsored, performed by the Kaiser Permanente Division of Research in Oakland, CA, assessing risk factors for respiratory syncytial virus (RSV) infection requiring medical treatment in infants born at 33 weeks gestational age [GA] or later.
MedImmune has awarded grants to five pediatric fellows to assist their conduct of original research in the field of viral respiratory diseases. For the sixth consecutive year, MedImmune commits $175,000.
Abraxis BioScience presents preclinical and clinical results from 10 studies evaluating chemotherapeutic agent ABRAXANE (R), SPARC Biomarker and Other Nab(R) Pipeline Therapies at AACR Annual Meeting.
The Asthma and Allergy Foundation of America:New nationwide survey of 1,001 patients found most asthma patients know the risks of "uncontrolled asthma," but misinterpret asthma control, not realizing that asthma is a chronic disease that requires long-term therapy "“ even when symptoms are not present.
Results from three newly presented studies evaluating the maintenance combination asthma therapy, SYMBICORT (budesonide/formoterol fumarate dihydrate), showed significant improvement in small airway function in patients ages 12 years and older with asthma previously receiving inhaled corticosteroid (ICS) therapy.
A new study addresses the growing controversy among dental health professionals regarding the best course of treatment when evaluating between a root canal or dental implant procedure. Researchers evaluated the success and failure rates of teeth treated with a root canal (endodontically treated teeth) or extracted and replaced with a dental implant.
Data presented today from two pivotal efficacy and safety trials, SHINE and SUN, demonstrated that SYMBICORT (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol significantly improved lung function and was well-tolerated in patients with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD) relative to budesonide and formotorol administered alone, and placebo.
MedImmune announced today it will present nine abstracts at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th Annual Meeting of Infectious Disease Society of America (IDSA). These abstracts advance the knowledge about respiratory syncytial virus (RSV) and influenza, providing valuable insight into infectious disease prevention and underscoring MedImmune's leadership in this disease category.
A 5,000-person, five-country study released today by Edelman shows that people want more active, trusted, and personal health interaction with companies, organizations and brands, effectively rewriting the "rules of engagement" in health. The Edelman Health Engagement Barometer finds that to win a "license to engage," companies must, above all, help people address their specific personal health concerns and help them maintain their health through prevention and care. They also must provide people with thorough, transparent, and specific information; engage them through personal and health-expert channels, online and off; and address personal issues like health and well-being before larger societal concerns.
Five neonatology fellows have been awarded grants designed to stimulate interest and research in the area of follow-up care of the premature infant as part of MedImmune's Fellowship Program. The grants, which underscore MedImmune's commitment to expanding research within pediatric medicine, will provide each recipient's institution a $35,000 grant, totaling $175,000 in research funding. The five recipients were acknowledged on Sunday, October 12, 2008 at a reception coinciding with the American Academy of Pediatrics (AAP) 2008 National Conference and Exhibition.
MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2008 National Conference & Exhibition that add to the company's growing body of research into the prevention of respiratory syncytial virus (RSV), a leading cause of viral respiratory infection among preterm infants.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right